Multicenter phase II study of lurbinectedin in BRCAMutated and unselected metastatic advanced breast cancer and biomarker assessment substudy.
Journal of Clinical Oncology.
Times cited: 5
Interrogating open issues in cancer precision medicine with patient-derived xenografts.
Nature Reviews Cancer.
Times cited: 176
Clinical benefit of lapatinib-based therapy in patients with human epidermal growth factor receptor 2-positive breast tumors coexpressing the truncated p95HER2 receptor.
Clinical Cancer Research.
Times cited: 95
Metalloprotease-disintegrin MDC9: Intracellular maturation and catalytic activity.
Journal of Biological Chemistry.
Times cited: 253